Human Rabies Immunoglobulin (HRIG)

[Dosage Form] 

It is  clear, colorless or light yellow liquid. Opalescence may occur but without turbidity.

[Indication] 

The product is indicated for passive immunization of persons with wounds bitten or scratched by rabid dogs or other animals carrying rabies virus.

[Specifications] 

200 IU per container (2.0 ml): each container containing 200 IU of rabies antibody potency, filling quantity of 2.0 ml.

500 IU per container (5.0 ml): each container containing 500 IU of rabies antibody potency, filling quantity of 5.0 ml.

200 IU per Pre-filled syringe (2.0 ml): each container containing 200 IU of rabies antibody potency, filling quantity of 2.0 ml. 

[Usage and dosage]

Usage: After extensive debridement, inject hypo. 1/2 of the total dosage at the wound, and inject i.m. the rest 1/2 (at back muscles if the wound was in head). WHO recommendation: Inject as much the product as possible at the wound; dilute 2～3 folds of the product with saline for use if the product is not enough.

Dosage: 20IU/kg BW or at the direction of the physician; the product should be used up at one time. If the dosage required exceeds 10 ml, divided dosing is allowed within 1～2 days. Afterwards, proceed the injection of rabies vaccine, but at a different site of injection and with a different equipment from that of the immunoglobulin.